2023 annual financial data
Candel Therapeutics 2023 Operating margin
Direct answer
Operating margin was -123,841.94%.
Operating income was -38.39M USD and net income was -37.94M USD.
Operating cash flow was Not available.
Get free Candel Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,000 USD
- Operating income
- -38.39M USD
- Net income
- -37.94M USD
- Operating cash flow
- Not available